Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biotech deals
Biotech
PE dealmaking, exit counts on the rise in Q3: PitchBook
The private equity market is showing signs of recovery, with strong deal activity and lower interest rates driving optimism.
Gabrielle Masson
Oct 20, 2025 5:05pm
Xoma and Lava buyout cools with lower offer
Oct 17, 2025 2:35pm
Astellas turns down option to license Taysha gene therapy—again
Oct 17, 2025 10:50am
Kite puts $1.64B on the line for Pregene's in vivo CAR-Ts
Oct 16, 2025 4:56pm
Dianthus offers up to $1B for China biotech’s autoimmune asset
Oct 16, 2025 10:57am
Evoq Therapeutics signs on with Sanofi in $500M partnership
Oct 16, 2025 10:25am